Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers
- PMID: 17228527
- PMCID: PMC2742383
Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers
Abstract
This position paper documents the merit of including for basic and clinical investigations the mapping of circadian and other rhythms and yet broader chronomes, time structures in and around us. Chronobiometry used herein relies on inferential statistical methods and on materials documented earlier. The circadian amplitude of melatonin is shown to relate both to cancer risk and to the presence of overt cancer, when no differences are found in the 24-hour average of melatonin. Optimization of treatment by timing, thoroughly documented along the circadian scale earlier, could be broadened to include optimization along the scale of the week, and eventually beyond. In both cases, reliance on marker rhythmometry is advocated. More generally, the limits of knowledge are expanded by considering already mapped spectral components and their characteristics that can be influenced by the dynamics of heliogeomagnetic signals heretofore unassessed.
Figures
References
-
- Halberg F, Cornélissen G, Wang ZR, Wan C, Ulmer W, Katinas G, Singh Ranjana, Singh RK, Singh Rajesh, Gupta BD, Singh RB, Kumar A, Kanabrocki E, Sothern RB, Rao G, Bhatt MLBD, Srivastava M, Rai G, Singh S, Pati AK, Nath P, Halberg Francine, Halberg J, Schwartzkopff O, Bakken E, Shastri VK. Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. J Exp Therapeutics Oncol. 2003;3:223–260. - PubMed
-
- Hrushesky WJM. The temporal organization of life: the impact of multi-frequency non-linear biologic time structure upon the host-cancer balance. Jpn J Clin Oncol. 2000;30:529–533. - PubMed
-
- Hrushesky WJM, Blask DE. Re: melatonin and breast cancer: a prospective study [correspondence] J Nat Cancer Inst. 2004;96:888–889. - PubMed
-
- Travis R, Allen D, Fentiman I, Key T. Melatonin and breast cancer: a prospective study. J Nat Cancer Inst. 2004;96:475–482. - PubMed
-
- Wetterberg L, Halberg F, Halberg E, Haus E, Kawasaki T, Ueno M, Uezono K, Cornélissen G, Matsuoka M, Omae T. Circadian characteristics of urinary melatonin from clinically healthy women at different civilization disease risk. Acta med scand. 1986;220:71–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical